Minutes of the Invention for Innovation (i4i) programme sub-committee meeting to discuss Stage 1 applications to call 11 of the i4i Challenge Awards.
Date and Location
Thursday 22 July 2021 Via online virtual meeting
In Attendance
Sub Committee
Professor Nick Lemoine (Chair)
Ms Jo Smart (Deputy Chair)
i4i secretariat
Professor Mike Lewis (Programme Director)
Dr Ruth Nebauer (Assistant Director)
Dr Fanny Burrows
Dr Aayesha Hassan
Ms Ami Hodges
Mrs Paula Milton
Dr Ian Newington
Ms Deimante Normantaite
Dr Sandra Nwokeoha
Miss Rhanda Tajdeen
Mr Edwin Tucker
Dr Xi Ye
Stage 1 applications invited to submit to Stage 2
NIHR203393: Case finding of obstructive sleep apnoea in primary care using a novel device: a randomised controlled trial
Outcome: Invite to Stage 2
NIHR203420: Real World Testing and Cost-effectiveness Analysis of Subcutaneous EEG (REAL-ASE)
Outcome: Invite to Stage 2
NIHR203421: Artificial Intelligence and computer-assisted technology for staging breast and colorectal carcinoma: real-life validation to resolve the challenges of translating research into a safe and efficient diagnostic service provision.
Outcome: Invite to Stage 2
NIHR203424: Comparison of health outcomes in a remote monitoring programme versus usual care in Interstitial Lung Disease
Outcome: Invite to Stage 2
NIHR203425: A randomised controlled trial of the effectiveness of surface neuromuscular stimulation using the geko™ device compared with intermittent pneumatic compression to prevent venous thromboembolism in immobile acute stroke patients
Outcome: Invite to Stage 2
NIHR203427: Assessment of PDMonitor®: benefits of wearable devices and telehealth in Parkinson’s Disease in improving patient's quality of life and driving healthcare efficiencies
Outcome: Invite to Stage 2
Stage 1 applications not invited to submit to Stage 2
NIHR203422: The real-world implementation of superficial hyperthermia machine in combination with radiotherapy in the NHS
Outcome: Reject
NIHR203423: Real-world implementation study to evaluate the clinical, patient, and healthcare benefits of the Cleara Talk nasal obturator in patients with hypernasal speech
Outcome: Reject
NIHR203426: Clinical validation of a novel digitally enabled model for more sustainable, safe and productive General Practice consultations
Outcome: Reject
NIHR203428: Feasibility Assessment of a product employing Bayesian methods for dynamic modelling of Atrial Fibrillation (AF) prediction in cardiac critical care.
Outcome: Reject